NIH Starts Antibody Trials As Trump Admin Urges Blood, Plasma Donations

The National Institutes of Health on Tuesday (Aug. 4) launched two randomized controlled clinical trials to test multiple monoclonal antibody treatments for use against COVID-19. The trials come as President Donald Trump and HHS officials urge people who have recovered from coronavirus to donate blood and plasma to help develop passive immunotherapies, which includes convalescent plasma and monoclonal antibodies, that can be used against SARS-CoV-2. National Institute of Allergy and Infectious Diseases Director Anthony Fauci recently touted the potential for...